Company page

Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. (ticker: HRMY) is a public company based in the United States with a market capitalization of approximately $1.93 billion. The company focuses on developing and commercializing innovative therapies for patients with rare neurological disorders. Harmony Biosciences is dedicated to addressing unmet medical needs in this specialized market.

profileHRMY:NASDAQAI content: aiUpdated June 24, 2026/company/harmony-biosciences-holdings/c-8xvi0zrb
Harmony Biosciences Holdings, Inc. logo
Ticker
HRMY:NASDAQ
Asset type
Stock
Market cap
$1.93B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD